Precipio (NASDAQ: PRPO) is having yet another strong start to the trading session this morning, and for good reason. The comapny reminded investors of a coming conference call that will likely act as a catalyst amidst a slew of great news. Today, we’ll talk about:
- Why PRPO stock is climbing;
- what we’re seeing from the stock; and
- what we’ll be watching for ahead.
Why PRPO Stock Is Climbing
As mentioned above, Precipio is having a strong day in the market today after reminding investors of a coming conference call in a press releas. While the call is important, the news leading up to the call is what has investors so excited.
For those of you who would like to join, the conference call will take place on May 6, 2019 at 5:00 Eastern Time. To dial in, call (844) 695-5519. International callers may dial in at 1 (412) 902-6760. You may also pre-register at this link.
Nonetheless, the meat and potatoes of the call will likely act as a positive catalyst based on all of the news that’s been released. I’ve followed and reported on the news in detail here, but for those of you who haven’t been following, here’s what’s happening:
PRPO recently announced that it would be taking its products to the global scale. In doing so, the company has hired Ori Karev as its Chief Strategy Officer. Karev brings with him an impressive rolodex after helping UnitedHealthcare Global penetrate more than 100 global markets.
As a result of his early work, the company has already signed a big agreement in Egypt that’s likely to generate meaningful revenues this year. With that said, investors are excited to hear the update regarding PRPO activities to further penetrate the global market.
What We’re Seeing From The Stock
One of the first lessons that we learn when we start to dig into the market is that the news leads to moves. When it comes to Precipio, recent news has been overwhelmingly positive.
After all, the company’s quick entrance into the global marketplace is likely to lead to a substantial increase in revenue sooner rather than later. So, it’s not surprising that excited investors are pushing the stock on a run for the top.
As is just about always the case, our partners at Trade Ideas were the first to alert us to the gains. Currently (9:44), PRPO is trading at $9.19 per share after a gain of $0.79 per share or 9.40% thus far today.
Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!
What We’ll Be Watching For Ahead
Moving forward, the CNA Finance team will continue to keep a close eye on PRPO. In particular, we’re interested in following the story surrounding the company’s continued work to bring its cancer diagnostic products around the world as this move has the potential to generate tremendous value for investors. Nonetheless, we’ll keep a close eye on the news and bring it to you as it breaks!
Never Miss The News Again
Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!